Nine months after participating in an immunotherapy clinical trial for his late stage melanoma, Howard is cancer-free. Dr. Anna Pavlick and Dr. Jeffrey Weber, our melanoma program co-directors, discuss how targeted therapy and personalized care helped make this outcome a reality.

Learn more about our approach to treating melanoma at [ Ссылка ]

свернуть